Cancer Center Support Grant

癌症中心支持补助金

• 批准号: 8907926
• 负责人: ROY A. JENSEN
• 金额: $ 151万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-11 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8907926
• 关键词: Academia; Accounting; Adoption; Agreement; American; Antineoplastic Agents; Area; Biostatistics Shared Resource; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cancer Control; Cancer Patient; Cancer Research Project; Catchment Area; Cities; Clinical; Clinical Research; Clinical Trials; Communities; Development; Diagnosis; Disease; Doctor of Medicine; Ensure; Environment; Family; Fostering; Funding; Goals; Government; Industry; Informatics; Institutes; Institution; Kansas; Laboratories; Lead; Leadership; Life; Malignant Neoplasms; Medical Research; Medical center; NCI Center for Cancer Research; NCI-Designated Cancer Center; Oncologist; Pharmacotherapy; Phase I Clinical Trials; Positioning Attribute; Recruitment Activity; Research; Research Personnel; Resource Sharing; Secure; Services; Technology; Therapeutic; Universities; Wichita; base; cancer prevention; drug discovery; fight against; implementation research; improved; meetings; member; novel therapeutic intervention; novel therapeutics; oncology; population based; population health; programs; survivorship

DESCRIPTION (provided by applicant): The University of Kansas Cancer Center (KUCC) is a matrix cancer center that includes: the University of Kansas Medical Center campuses in Kansas City and Wichita, the University of Kansas-Lawrence, and the Stowers Institute for Medical Research (via consortium agreement). In 2010, 143 members of KUCC accounted for $11.4 million of NCI funding and a total of $55.1 million in overall cancer-related funding. KUCC is led by Roy A. Jensen, M.D. who is supported by a strong, nationally recognized leadership team. Over the last seven years substantial progress has been made securing institutional commitment, recruiting key leadership positions, building nationally significant research programs, developing our clinical research program, improving and expanding our facilities, and creating transdisciplinary and collaborative interactions. With input from our External Advisory Board, we have established three goals for KUCC that will insure we make a national impact in the fight against cancer: Goal 1: Become the leading academic institution for transforming discoveries from the laboratory into new anticancer drug therapies. Goal 2: Provide the optimal environment for basic, translational, clinical, and population-based research in oncology by developing and fostering a collaborative, collegial, and dynamic culture of scientific inquiry. Goal 3: Be a nationally recognized leader in partnering with community oncologists and other key stakeholders to develop, promote, and foster the adoption and implementation of research-based cancer prevention, diagnosis, treatment, control, and survivorship practices throughout our service area. To accomplish these goals KUCC has four research programs including: Cancer Biology, Cancer Control and Population Health, Cancer Prevention, and Drug Discovery, Delivery and Experimental Therapeutics. In addition, the Cancer Center supports four shared resources: Biostatistics and Informatics, Lead Development and Optimization, Biospecimen, and Clinical Trials Management.

描述（由申请人提供）：堪萨斯大学癌症中心 (KUCC) 是一个矩阵癌症中心，包括：位于堪萨斯城和威奇托的堪萨斯大学医学中心校区、堪萨斯大学劳伦斯分校以及斯托尔斯医学研究所研究（通过联盟协议）。 2010年，KUCC的143名成员获得了NCI资助1140万美元，癌症相关资助总计5510万美元。 KUCC 由医学博士 Roy A. Jensen 领导，并得到全国认可的强大领导团队的支持。在过去的七年里，我们在确保机构承诺、招聘关键领导职位、建立全国性重要研究项目、开发我们的临床研究项目、改进和扩大我们的设施以及建立跨学科和协作互动等方面取得了重大进展。根据外部顾问委员会的意见，我们为 KUCC 制定了三个目标，以确保我们在抗击癌症方面产生全国影响： 目标 1：成为将实验室发现转化为新抗癌药物疗法的领先学术机构。 目标 2：通过发展和培育协作、合作和动态的科学探究文化，为肿瘤学的基础、转化、临床和人群研究提供最佳环境。 目标 3：成为全国公认的领导者，与社区肿瘤学家和其他主要利益相关者合作，在我们的服务领域开发、促进和促进基于研究的癌症预防、诊断、治疗、控制和生存实践的采用和实施。 为了实现这些目标，KUCC 有四个研究项目，包括：癌症生物学、癌症控制和人口健康、癌症预防以及药物发现、输送和实验治疗。此外，癌症中心还支持四种共享资源：生物统计学和信息学、先导化合物开发和优化、生物样本和临床试验管理。